Time-Dependent Transfusion Status as an Independent Predictor of Overall Survival: A Post Hoc Analysis of 3 Phase 3 Trials

被引：0
|
作者：
Gupta, Vikas [1 ]
Harrison, Claire [2 ]
Gorsh, Boris [3 ]
Patel, Bharat [4 ]
Wang, Zhaohui [3 ]
Purser, Molly [3 ]
Ellis, Catherine [3 ]
Strouse, Bryan [3 ]
Patnaik, Dwaipayan [5 ]
Kawashima, Jun [6 ]
Mesa, Ruben [7 ]
机构：
[1] Princess Margaret Canc Ctr, Toronto, ON, Canada
[2] Guys & St Thomas NHS Fdn Trust, London, England
[3] GSK Plc, Philadelphia, PA USA
[4] GSK Plc, London, England
[5] GSK Plc, Baar, Switzerland
[6] Sierra Oncol, San Mateo, CA USA
[7] Atrium Hlth Wake Forest Baptist Comprehens Canc C, Winston Salem, NC USA
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2024年 / 24卷
关键词：
anemia; JAK inhibitors; myelofibrosis; overall survival; transfusion dependence; transfusion independence;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MPN-086
引用
收藏
页码：S410 / S410
页数：1
相关论文
共 50 条
  • [1] Red Blood Cell Transfusion Independence Status Is an Independent Predictor of Survival: A Post Hoc Time-Dependent Analysis of the Phase 3 Simplify-1, Simplify-2, and Momentum Trials
    Gupta, Vikas
    Harrison, Claire N.
    Gorsh, Boris
    Patel, Bharat
    Wang, Zhaohui
    Purser, Molly
    Ellis, Catherine
    Strouse, Bryan
    Patnaik, Dwaipayan
    Kawashima, Jun
    Mesa, Ruben A.
    BLOOD, 2023, 142
  • [2] Filgotinib Demonstrates Efficacy in Rheumatoid Arthritis Independent of Smoking Status: Post Hoc Analysis of Phase 3 Trials and Claims-Based Analysis
    Jeffrey R. Curtis
    Paul Emery
    Bryan Downie
    Yan Zhong
    Jinfeng Liu
    Ling Han
    Rachael E. Hawtin
    Gerd Rüdiger Burmester
    Rheumatology and Therapy, 2024, 11 : 177 - 189
  • [3] Filgotinib Demonstrates Efficacy in Rheumatoid Arthritis Independent of Smoking Status: Post Hoc Analysis of Phase 3 Trials and Claims-Based Analysis
    Curtis, Jeffrey R.
    Emery, Paul
    Downie, Bryan
    Zhong, Yan
    Liu, Jinfeng
    Han, Ling
    Hawtin, Rachael E.
    Burmester, Gerd Ruediger
    RHEUMATOLOGY AND THERAPY, 2024, 11 (01) : 177 - 189
  • [4] FILGOTINIB DEMONSTRATES CLINICAL EFFICACY IN RHEUMATOID ARTHRITIS INDEPENDENT OF SMOKING STATUS: A POST-HOC SUBGROUP ANALYSIS OF THREE PHASE 3 CLINICAL TRIALS
    Emery, Paul
    Downie, Bryan
    Liu, Jinfeng
    Hawtin, Rachael E.
    Curtis, Jeffrey R.
    Burmester, Gerd R.
    RHEUMATOLOGY, 2022, 61
  • [5] FILGOTINIB DEMONSTRATES CLINICAL EFFICACY IN RHEUMATOID ARTHRITIS INDEPENDENT OF SMOKING STATUS: A POST-HOC SUBGROUP ANALYSIS OF THREE PHASE 3 CLINICAL TRIALS
    Emery, P.
    Downie, B.
    Liu, J.
    Hawtin, R.
    Curtis, J. R.
    Burmester, G. R.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 502 - 502
  • [6] The relationship between repeat resection and overall survival in patients with glioblastoma: a time-dependent analysis
    Goldman, Debra A.
    Hovinga, Koos
    Reiner, Anne S.
    Esquenazi, Yoshua
    Tabar, Viviane
    Panageas, Katherine S.
    JOURNAL OF NEUROSURGERY, 2018, 129 (05) : 1231 - 1239
  • [7] Evaluation of quality of life as an early surrogate of overall survival: An analysis from phase 3 immunotherapy trials
    Shahnam, Adel
    Nindra, Udit
    Hui, Rina
    Hopkins, Ashley M.
    Sorich, Michael J.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2022, 18 : 98 - 98
  • [8] Momelotinib in Myelofibrosis Patients With Thrombocytopenia: Post Hoc Analysis From Three Randomized Phase 3 Trials
    Kiladjian, Jean-Jacques
    Vannucchi, Alessandro M.
    Gerds, Aaron T.
    Gupta, Vikas
    Verstovsek, Srdan
    Egyed, Miklos
    Platzbecker, Uwe
    Mayer, Jiri
    Grosicki, Sebastian
    Illes, Arpad
    Wozny, Tomasz
    Oh, Stephen T.
    McLornan, Donal
    Kirgner, Ilya
    Yoon, Sung-Soo
    Harrison, Claire N.
    Klencke, Barbara
    Huang, Mei
    Kawashima, Jun
    Mesa, Ruben
    HEMASPHERE, 2023, 7 (11): : E963
  • [9] Overall survival of patients post-transplant: study results from two phase 3 trials ASPIRE and ENDEAVOR
    Goldschmidt, Hartmut
    Mateos, Maria-Victoria
    Siegel, David
    Abonour, Rafat
    Ludwig, Heinz
    Obreja, Mihaela
    Iskander, Karim Saad
    Hari, Parameswaran
    BONE MARROW TRANSPLANTATION, 2018, 53 : 654 - 655
  • [10] Overall Survival of Patients Post-Transplant: Study Results from Two Phase 3 Trials ASPIRE and ENDEAVOR
    Goldschmidt, Hartmut
    Mateos, Maria-Victoria
    Siegel, David
    Abonour, Rafat
    Ludwig, Heinz
    Obreja, Mihaela
    Iskander, Karim Saad
    Hari, Parameswaran
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 : S238 - S239
12345